Learn More About Wet AMD Eye Exams and What to Expect
Wet Age-Related Macular Degeneration (Wet AMD) is an advanced form of macular degeneration characterized by the growth of abnormal, fragile blood vessels beneath the retina. These vessels can leak fluid, lipids, or blood into the macula—the central portion of the retina responsible for sharp, straight-ahead vision—causing rapid, severe central vision distortion or loss.
Because wet AMD progresses much faster than dry AMD, undergoing comprehensive eye exams is crucial for timely diagnosis and monitoring.

Why a Comprehensive Dilated Eye Exam Is Essential
Routine screenings for glasses or quick eye checks cannot evaluate the fine vascular structures of the retina. A comprehensive dilated eye exam allows an eye care specialist (an optometrist or retina specialist) to look directly through the pupil to evaluate structural health, identify fluid accumulation, and detect early vessel leakage.
What Happens During a Wet AMD Evaluation
A diagnostic examination for wet AMD involves several sequential tests:
[ Diagnostic Flow for Wet AMD ]
|
+----------------------+----------------------+
| |
[ Functional Testing ] [ Structural Imaging ]
| |
• Visual Acuity Test • Optical Coherence Tomography (OCT)
• Amsler Grid Assessment • Fluorescein Angiography (If Needed)
-
Visual Acuity & Amsler Grid Testing:
-
Visual Acuity: Measures clarity of vision at distance using a standard eye chart.
-
Amsler Grid: A grid of straight horizontal and vertical lines with a central dot. Looking at the grid helps identify areas where straight lines appear wavy, bent, broken, or dark—a classic indicator of macular swelling or fluid buildup.
-
-
Pupil Dilation & Ophthalmoscopy:
-
Eyedrops enlarge (dilate) the pupils, allowing the specialist to use a specialized microscope (slit lamp) and magnifying lenses to inspect the back of the eye for fluid, hemorrhages, or yellow deposits (drusen).
-
Advanced Retinal Imaging Techniques
To confirm a diagnosis and pinpoint the location of fluid leakage, eye specialists rely on non-invasive structural imaging:
|
Imaging Test |
How It Works |
What It Reveals |
|---|---|---|
|
Optical Coherence Tomography (OCT) |
Uses light waves to take cross-sectional, 3D images of the retina in seconds. |
Shows exact thickness of the retina and detects microscopic pockets of fluid trapped beneath or within retinal layers. |
|
Fluorescein Angiography (FA) |
A special fluorescent dye is injected into an arm vein; a specialized camera takes rapid photos as the dye flows through retinal vessels. |
Identifies active, leaking abnormal blood vessels and maps their exact pattern and location. |
Vision Changes That Warrant Immediate Evaluation
Wet AMD can develop suddenly or progress rapidly. Schedule an immediate evaluation with an eye care professional if you notice:
-
Distorted Straight Lines: Straight edges (like doorframes, lines of text, or window blinds) appearing wavy, curved, or bent.
-
Central Blind Spots: A dark, blurry, or empty patch appearing near the center of your visual field.
-
Color Alterations: Colors appearing faded, less vibrant, or difficult to distinguish.
-
Sudden Bluriness: Rapid decline in your ability to read, recognize faces, or see fine details.
How Exam Results Guide Treatment and Follow-Up Care
Exam findings directly inform personalized treatment plans. If active leakage from wet AMD is confirmed, treatments can include:
-
Anti-VEGF Injections: Medications injected directly into the eye gel to block the protein (VEGF) driving abnormal vessel growth, stopping leakage and helping preserve central vision.
-
Photodynamic Therapy (PDT): A light-activated drug and non-thermal laser used in specific cases to target and seal leaking vessels.
Because wet AMD is a chronic condition, regular follow-up appointments and serial OCT scans are vital to monitor treatment response, check for recurrent fluid, and adjust medication schedules to protect long-term sight.
Anti-VEGF (Vascular Endothelial Growth Factor) injections are the primary medical treatment for wet age-related macular degeneration (wet AMD). They work by targeting the specific chemical signals that drive abnormal, vision-threatening blood vessel growth in the eye.
How Anti-VEGF Injections Work
In wet AMD, low oxygen levels or retinal stress trigger the overproduction of a signal protein called VEGF. Excess VEGF stimulates the growth of weak, abnormal blood vessels underneath the macula that easily leak blood and fluid.
[ Overproduction of VEGF Protein ]
|
v
[ Weak, Abnormal Blood Vessel Growth ]
|
v
[ Fluid & Blood Leakage Beneath Macula ]
|
v
+-----------------------------------------------------------------+
| [ Anti-VEGF Medication Injected ] |
+-----------------------------------------------------------------+
|
+-----------------------------+-----------------------------+
| |
[ Binds & Blocks VEGF ] [ Dries Fluid ]
| |
• Stops new vessel growth • Clears existing leakage
• Prevents vessel breakdown • Reduces macular swelling
-
Blocking the Signal: The injected medication binds directly to excess VEGF proteins in the eye, preventing them from docking onto blood vessel receptors.
-
Stopping New Growth: Without active VEGF signaling, the eye stops growing new, fragile blood vessels.
-
Closing Leaks: Existing abnormal vessels shrink and stop leaking fluid into the retina.
-
Preserving Vision: Resolving retinal swelling stabilizes central vision and helps prevent permanent scarring of the macula.
Commonly prescribed anti-VEGF agents include aflibercept, ranibizumab, bevacizumab, and faricimab.
Typical Treatment Schedules
Because anti-VEGF medications wear off over time, treatment requires ongoing administration. Injections are performed in an outpatient clinic using numbing drops to ensure comfort.
Retina specialists typically use one of three dosing strategies tailored to how individual eyes respond:
|
Dosing Strategy |
How It Works |
Advantages / Frequency |
|---|---|---|
|
Loading Phase (Initiation) |
Injections given once every 4 weeks for the first 3 months (3 initial doses). |
Establishes control over vessel leakage and dries macular swelling quickly. |
|
Treat-and-Extend (T&E) |
After the loading phase, intervals between injections are extended by 1–2 weeks if the retina remains dry, or shortened if fluid returns. |
Most common approach. Reduces total clinic visits while keeping the disease actively suppressed (typically every 8 to 16 weeks). |
|
Fixed Interval |
Regular, scheduled injections given every 4, 8, or 12 weeks regardless of minor imaging fluctuations. |
Predictable scheduling; useful for high-risk eyes with persistent activity. |
|
Pro Re Nata (PRN / As Needed) |
Patient receives monthly exams with OCT scans, but injections are given only when active fluid is detected. |
Minimizes total injections, but requires strict monthly clinic visits to avoid missing recurrent fluid. |
What to Expect Long-Term
Wet AMD is a chronic condition, so anti-VEGF therapy is generally a long-term commitment rather than a short-term cure. Continuous monitoring with Optical Coherence Tomography (OCT) scans allows retina specialists to adjust injection frequencies over time, aiming to maintain maximum visual acuity with the fewest necessary treatments.